Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | -0.0088 | 0.8 |
mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | 0.0093 | 0.8 |
mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.0093 | 0.8 |
mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.8 |
mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.0092 | 0.8 |
mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.009 | 0.8 |
mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
mRNA | XL765 | CTRPv2 | pan-cancer | AAC | 0.0095 | 0.8 |
mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.008 | 0.8 |
mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | 0.0095 | 0.8 |